Therapeutic procedures of sublingual immunotherapy in clinical practice

Chemical Immunology and Allergy

Volumn 82, Issue , 2003, Pages 44-52

  Zwacka, Gerhard ^a,c   Markert, U R ^b  

^a Robert Koch Hospital Gehrden   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Robert Koch Krankenhaus Apolda   (Germany)

Author keywords

Allergy; Sublingual immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPRURITIC AGENT; CETIRIZINE; CORTICOSTEROID; CYTOKINE; EBASTINE; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOMODULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; PARIETARIA JUDAICA ALLERGEN; PIMECROLIMUS; POLLEN ANTIGEN; TACROLIMUS; UNCLASSIFIED DRUG; ZAFIRLUKAST; ALLERGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ATOPIC DERMATITIS; BIRCH; BRONCHUS MUCOSA; BURNING SENSATION; CHEEK MUCOSA; CHEEK MUCOSA EDEMA; CLINICAL PRACTICE; CONJUNCTIVA EPITHELIUM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ECZEMA; GLOSSITIS; GRASS; HUMAN; IMMUNOTHERAPY; INFLAMMATION; MOUTHWASH; NOSE MUCOSA; PARESTHESIA; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS; RELIABILITY; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; TONGUE DISEASE; TONGUE EDEMA; DESENSITIZATION; HYPERSENSITIVITY; PROCEDURES; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANTI-INFLAMMATORY AGENTS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY;

EID: 0346997029     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071539     Document Type: Review

References (35)

1. Grossmann J: One airway, one disease. Chest 1997;111(suppl):11S-16S.
2. Rowe-Jones JM: The link between the nose and lung, perennial rhinitis and asthma: Is it the same disease? Allergy 1997;52:8-20.
3. Vignola AM, Crampette L, Mondain M, Sauvere G, Czarlewski W, Bousquet J, Campbell AM: Inhibitory activity of loratidine on cells. Allergy 1995;50:200-203.
4. Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Michel F-B: Asthma a disease remodelling the airways. Allergy 1992;47:3-11.
5. Jeffry PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma: An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
6. Pattemore PK, Johnston SL, Bardin PG: Virus as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992;22:325-336.
7. Canonica GW: Adhesion molecules in allergy. Role of adhesion molecules in the pathophysiology of allergy. J Investig Allergol Clin Immunol 1997;7:274-276.
8. Wiedermann U, Kraft D: Induction of mucosal tolerance to Bet v 1, the major birch pollen allergen, a review. Allergy Clin Immunol Int 2002;14:17-24.
9. Stingl G, Maurer D: IgE mediated allergen presentation via FcERI on antigen-presenting cells. Int Arch Allergy Immunol 1997;113:24-29.
10. Masieri S, Cavaliere F, Filiaci F: Nasal obstruction improvement induced by topical furosemide in subjects affected by perennial nonallergic rhinitis. Am J Rhinol 1997;11:443-447.
11. Vignola AM, Chanez P, Godard P, Bosquet J: Relationships between rhinitis and asthma. Allergy 1998;53:833-839.
12. Ciprandi G, Ricca V, Passalacqua G, Fasolo A, Canonica GW: Intranasal fluticasone proprionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge. Clin Exp Allergy 1998;28:293-299.
13. Wright ED, Christodoulopoulas P, Small P, Frenkie S, Hamid Q: Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids. Larnygoscope 1999;109:551-556.
14. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW: Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96:971-979.
15. Fasce L, Ciprandi G, Pronzato C, Cozzani S, Tosca MA, Grimaldi I, Canonica GW: Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272-276.
16. Fokkens WJ, Godthelp T, Holm AF, Klein JA: Local corticosteroid treatment: The effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol 1998;12:21-26.
17. Ricca V, Landi M, Ferrero P, Bairo A, Tazzer C, Canonica GW, Ciprandi G: Minimal persistent inflammation is also present in patient with seasonal allergic rhinitis. J Allergy Clin Immunol 2000;105:54-57.
18. Meltzer E, Malmstrom K, Lu S, Brenner B, Wie L, Weinstein S, et al: Concomitant montelukast and loratidine as treatment for seasonal allergic rhinitis. Placebo-controlled clinical trail. J Allergy Clin Immunol 2000;105:917-922.
19. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC: Sublingual immunotherapy in Parietaria pollen-induced rhinitis: A double-blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
20. Clavel R, Bousquet J, Andre C: Clinical efficacy of sublingual-swallow immunotherapy: A doubleblind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-498.
21. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, Pauli G, Caillaud D, Dubost R, Leynadier F, Vervloet D, Herman D, Galvain S, Andre C: Sublingualswallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study. Allergy 1999;54:249-260.
22. La Rosa M, Ranno C, Andri C, Carat F, Tosca MA, Canonica GW: Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
23. Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S, Canonica GW: Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J Allergy Clin Immunol 1999;104:964-968.
24. Purello-D'Ambrosio F, Gangemi S, Isola S, La Motta N, et al: Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietariajudaica extract standardized in mass units in patients with rhiniconjunctivitis, asthma, or both. Allergy 1999;54:968-973.
25. Pajno GB, Morabito L, Barberio G, Parmiani S: Clinical and immunology effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, placebo-controlled study. Allergy 2000;55:842-849.
26. Bousquet J, Cauvenberge PV, Khaltaev N: Allergic rhinitis and its impact on asthma - ARIA Workshop Report. J Allergy Clin Immunol 2001;108(5 suppl):147-334.
27. Bagnasco M, Mariani G, Passalacqua G, Motta C, Bartolomei M, et al: Absorbtion and distribution kinetics of the major Paritaria judaica allergen (Parj 1) administered by noninjectable routes in healthy humans beings. J Allergy Clin Immunol 1997;100:122-129.
28. Igea JM, Cuevas M, Lazaro M: Susceptibility of grass-pollen immunotherapy extract to the salvia and gastric fluid digestive process. Allergol Immunopathol 1994;22:55-59.
29. Blanas E, Davey GM, Carbone FR, Heath WR: A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol 2000;164:2890-2896.
30. Silvestri M, Rossi GA, Cozzani S, Pulvirenti G, Fasce L: Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999;83:335-340.
31. Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S, Ricciardi L: Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31:1295-1302.
32. Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, Andre C: Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-828.
33. Andre C, Vatrinet C, Galvain S, Carat FD, Sicard H: Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-234.
34. Guez S, Vatrinet C, Fadel R, Andre C: House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study. Allergy 2000;55:369-375.
35. Lombardi C, Passalacqua G, Gargioni S, Berard M: The safety of sublingual immunotherapy in patients with oral allergy syndrome (abstract). Allergy 2000;55(suppl 63):116.